In percutaneous coronary intervention (PCI), chronic total occlusion (CTO) coronary artery disease still remains difficult to treat. One of the reasons for the failure is the hard of the CTO lesions that balloon is difficult to pass through or expand. Previous methods to deal with CTO lesions that cannot be passed by balloon, include selecting reinforced catheter (such as 5 in 6 guiding catheter, Guidzilla catheter, or Tornus microcatheter), guidewire extrusion or rotary grinding technology. In recent years, excimer laser coronary angioplasty (ELCA) has been gradually applied to CTO lesions. Using inert halide as the laser medium, ELCA emits a 308 nm high-intensity unidirectional light wave with absorption depth of only 50 µmL, resulting in less thermal effect and less damage to non-target lesions. In this paper, we will describe a successful PCI case of an in-stent CTO lesion using ELCA with long term coronary angiography follow-up.

A 59-year-old female presented with severe chest pain after performing physical activities for seven years. Her symptoms remained stable until five years before her hospitalization in 2012. Her coronary angiography showed a chronic total occluded lesion in proximal of left anterior descending (LAD). This vessel was opened and implanted three stents from distal to proximal. The stent did not cover the ostium of LAD. However, the patient had an irregular medicine therapy after PCI. She stopped Aspirin and statins by herself one year ago, so that her symptoms aggravated again. She felt chest pain and could not walk for even hundreds of meters for three months. She was admitted in Chinese PLA General Hospital for unstable angina. The patient had a history of hypertension, cerebral hemorrhage with hemiplegia, and type 2 diabetes mellitus. The measurement of lipid profiles revealed that her LDL-C concentration was 2.74 mmol/L. NT pro-BNP was 141.6 pg/mL. The echocardiogram showed left ventricle ejection fraction was 60%. Electrocardiogram (ECG) showed ST-segment depressed in the anterior leads (V1-V6). Her coronary angiography showed the LAD was completely in-stent obstructive. ([Figure 1](#jgc-16-06-502-g001){ref-type="fig"})

![Coronary artery angiography.\
(A): LAD in-stent CTO lesion. Ipsilateral collateral circulation showed with an arrow; (B): LAD in-stent CTO lesion. Ipsilateral collateral circulation showed with an arrow; and (C): RCA angiography. The retrograde collateral circulation from RCA to LAD can be seen where the arrow points. CTO: chronic total occlusion; LAD: left anterior descending; RCA: right coronary artery.](jgc-16-06-502-g001){#jgc-16-06-502-g001}

The operation process is shown in [Figure 2](#jgc-16-06-502-g002){ref-type="fig"}. EBU 3.5 guiding was selected and Corsair microcatheter was used to increase support. However, Fielder XT and Miracle 6 guidewire could not pierce the proximal fibrous cap, and while the Conquest Pro guide wire could enter the occlusive section, but could not deliver distally. Finally, the guidewire of PILOT50 was successfully delivered to the distal lumen with difficulty. The guidewire was confirmed to enter the true lumen by retrograde angiography. The Corsair microcatheter could not be pushed forward, and the 1.2 mm small balloon also failed to pass through the lesion. Then we used 0.9 mm Spectranetics laser ablation catheter, with 45 mj/mm^2^ delivering energy level, 45 Hz pulse frequency, 0.5 mm/s forward speed. After the first ELCA, the LAD restored anterior blood flow to TIMI 3 level. In order to achieve larger lumen, ablation was performed a second time with 60 mj/mm^2^ delivering energy level and 60 Hz pulse frequency. It was found that the residual restenosis was further reduced. This interventional therapy routine has been shown in [Figure 3](#jgc-16-06-502-g003){ref-type="fig"}.

![ELCA procedure and outcomes.\
(A): Conquest pro wire successfully cross over the total occluded lesion with support of corsair micro-catheter; (B): 0.9 mm Spectranetics ELCA (arrow showed); (C): after ELCA with 45 mj/mm^2^ energy density, 45 Hz pulse frequency, and 0.5 mm/s running speed; and (D): after excimer laser angioplasty with 60 mj/mm^2^ energy density, 60 Hz pulse frequency, and 0.5 mm/s running speed. ELCA: excimer laser coronary angioplasty.](jgc-16-06-502-g002){#jgc-16-06-502-g002}

![PCI procedure and outcomes.\
(A): Flextome 2.25 mm × 10 mm cutting balloon predilation of 12 atmosphere; (B): angiography after cutting balloon pre-dilation; (C): SeQuent Please 2.5 mm × 30 mm drug coating balloon dilation; (D): 2.75 mm × 26 mm drug coating balloon dilation; (E): a Firebird2 3.0 mm × 23 mm stent was implanted in the ostium of LAD, expansion pressure was 16 atmosphere; and (F): final result after stent implantation. LAD: left anterior descending; PCI: percutaneous coronary intervention.](jgc-16-06-502-g003){#jgc-16-06-502-g003}

A Flextome 2.25 mm × 10 mm cutting balloon was used to expand the in-stent proliferative lesions at the pressure of 12 atm. SeQuent Please 2.5 mm × 30 mm and 2.75 mm × 26 mm drug coating balloons were used to cover intra-stent lesions within 60s after expansion. The proximal stenosis of the ostium of LAD was covered by Firebird2 3.0 mm × 23 mm stent, released with pressure of 16 atm. The final blood flow of LAD was TIMI 3 level, but the first diagonal branch disappeared and the septal branches were visibly obvious. Though the patient\'s symptoms were completely relieved, the postoperative TnT was tested to be slightly increased to 0.108 ng/mL (normal is \< 0.05 ng/mL). After stenting, the patient took medicine regularly for secondary coronary disease prevention. She had no symptoms and no restriction on physical activity. Coronary angiography of one year follow-up ([Figure 4](#jgc-16-06-502-g004){ref-type="fig"}) showed that the LAD still had TIMI 3 blood flow, and no obvious hyperplasia was observed. The first diagonal branch can be seen through collateral circulation from the circumflex. The septal branches are visibly clear.

![Angiography comparison of one-year follow-up: final result after PCI.\
(A): The first diagonal branch was disappeared. All the septal branches were not visible obvious; (B): final result after PCI; (C): one year follow up of angiography. The septal branches were more clearly visible than a year ago and the first diagonal branch could be seen by collateral circulation (arrow showed); and (D): one year follow up of angiography. The arrow shows septal branch which appeared after one year of PCI. PCI: percutaneous coronary intervention.](jgc-16-06-502-g004){#jgc-16-06-502-g004}

CTO lesions are often heavily calcified or fibrotic, and uncorrelated with the present balloon technology.[@b1] The attempts to treat them with balloon angioplasty or stent placement can lead to vessel dissection or incomplete stent expansion with adverse outcomes. Among some of these hard lesions, calcified stenosis, CTO, and non-compliant plaques pose major technical challenges in routine PCIs.[@b2]--[@b4] ELCA is a long-established adjunctive therapy that can be applied during PCI.[@b5],[@b6] In recent years, laser use has increased concomitantly with the performance of increasingly complex PCIs.[@b7] Excimer lasers are pulsed gas lasers that use a mixture of a rare gas and halogen as an active medium to generate pulses of short wavelength, high-energy ultraviolet (UV) light. The depth of laser penetration is directly related to its wavelength, with UV laser (shorter wavelength) having less depth of penetration, less heat production and less unwanted tissue damage.

ELCA can open channels for CTO lesions at the molecular level and change the compliance of lesions prior to direct balloon angioplasty. In a contemporary multicenter United States registry, ELCA was commonly used in highly complex lesions and was associated with high technical and procedural success rates.[@b8] The most common indication for ELCA was balloon-uncrossable lesions (43.8%), followed by balloon-undilatable lesions (40.8%) and thrombotic lesions (12.3%).[@b8] Use of ELCA was associated with high technical success rate (90.0%) and procedural success rate (88.8%), and low major adverse cardiac event rate (3.45%).[@b8] Mean procedure time was 120 min \[interquartile range (IQR): 81--191 min\], air kerma radiation dose was 2.76 Gy (IQR: 1.32--5.01 Gy), and contrast volume was 273 mL (IQR: 201--362 mL).[@b8] Laser is a powerful option for treating balloon-uncrossable lesions since it can be used over any standard 0.014″ guidewire, in contrast to rotational and orbital atherectomy, which require insertion of specialized guidewires that are often more difficult to deliver distally.[@b1] In-stent restenosis remains another major limitation of PCI following stent implantation with bare metal stent, although considerably less in the DES era. Excimer laser did not alter stainless-steel stent endurance or liberate any significant material when five types of stainless-steel stents were subjected.[@b9],[@b10]

Other than lack of informed consent and unprotected left main disease (a relative contraindication), there are no absolute coronary contraindications for ELCA. ELCA is not recommended when the operator is aware that there is a long length of sub-intimal guidewire positioning as may exist during hybrid PCI techniques for CTOs. ELCA complications are similar to those encountered during routine PCI. Specific issues may arise from interruption of the saline flush or contamination with contrast, which can generate excessive heat and increase the risk of vascular perforation.[@b11] When conventional interventional therapy is not successful, ELCA can often play an important role in benefiting patients.
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